BRAF and melanoma: Interestingly, a study by Shen et al. reported that BRAF mutant melanoma ‘persister’ cells resistant to BRAF/MEK inhibition switch their metabolism from glycolysis to oxidative phosphorylation that is predominantly dependent on perFAO compared to mitochondrial β-oxidation [21].